NEXTERONE (AMIODARONE HCI)

FDA Drug Profile — NEXTERONE (AMIODARONE HCI)

NEXTERONE (AMIODARONE HCI) is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including NEXTERONE (AMIODARONE HCI). Available dosage form: injection, solution.

Drug details

Generic Name
NEXTERONE (AMIODARONE HCI)
Brand Names
NEXTERONE (AMIODARONE HCI)
Application Number
NDA022325
Sponsor
HF Acquisition Co LLC, DBA HealthFirst
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
AMIODARONE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS & USAGE NEXTERONE is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. NEXTERONE also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with NEXTERONE, patients may be transferred to oral amiodarone therapy [see Dosage and Administration ( 2 )]. Use NEXTERONE for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but NEXTERONE may be safely administered for longer periods if necessary.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.